Study ID: NCT01570998
Accepting New Patients
Breast Cancer
Intraoperative Radiation Therapy, Laboratory Biomarker Analysis
Study ID: NCT01871896
Accepting New Patients
Obesity, Weight Loss
Endoscopic Suturing to Create Early Satiety
Study ID: NCT03551496
Accepting New Patients
Critical Limb Ischemia
Drug Eluting Stent - Below the Knee, Standard PTA Control Arm
Study ID: NCT03970538
Accepting New Patients
Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia, Arterial Occlusive Diseases, Arterial Occlusion, Peripheral Artery Occlusion, Vascular Disease, Peripheral Ischemia
Study ID: NCT04558775
Accepting New Patients
Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
Study ID: NCT04591691
Not Yet Accepting Patients
Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
Study ID: NCT04514861
Not Yet Accepting Patients
Peripheral Arterial Disease
Study ID: NCT02719665
Accepting New Patients
Peripheral Arterial Disease, Claudication, Claudication, Intermittent, Vascular Occlusion, Vascular Calcification, Vascular Disease, Osteoarthritis
SPM Emulsion, Dose-modality, SPM Softgel, Dose-Modality, Placebo Softgel
Study ID: NCT02620852
Accepting New Patients
Breast Cancer
Complete a health questionnaire, Provide a saliva sample for genetic testing, Screening advice based on a comprehensive risk assessment, Screening advice based on a basic risk assessment
Study ID: NCT00914017
Accepting New Patients
Breast Cancer
Atorvastatin, Placebo
Study ID: NCT01042379
Accepting New Patients
Breast Cancer, Breast Tumor
Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin, MK-2206 with or without Trastuzumab, AMG 386 and Trastuzumab, T-DM1 and Pertuzumab, Pertuzumab and Trastuzumab, Ganetespib, ABT-888, Neratinib, PLX3397, Pembrolizumab - 4 cycle, Talazoparib plus Irinotecan, Patritumab and Trastuzumab, Pembrolizumab - 8 cycle, SGN-LIV1A, Durvalumab plus Olaparib, SD-101 + Pembrolizumab, Tucatinib, Cemiplimab, Cemiplimab plus REGN3767
Study ID: NCT02872025
Accepting New Patients
Carcinoma, Intraductal, Noninfiltrating
Pembrolizumab
Study ID: NCT04488081
Accepting New Patients
COVID-19
Study ID: NCT03193151
Accepting New Patients
Liver Disease, Liver Transplant
liver biopsy
Study ID: NCT03654040
Not Yet Accepting Patients
Liver Transplant
arTreg, leukapheresis, cyclophosphamide, mesna, everolimus
Study ID: NCT00831090
Accepting New Patients
Peripheral Arterial Disease, Cardiovascular Disease
Study ID: NCT02807779
Accepting New Patients
Peripheral Arterial Disease, Vascular Disease, Critical Limb Ischemia, MRI
Dexamethasone infusion, Drug coated balloon
Study ID: NCT01310270
Accepting New Patients
Peripheral Arterial Disease
Pro-Omega, Omega 3 Fatty Acid
Study ID: NCT03477682
Accepting New Patients
Wound Complication
Early ambulation
Study ID: NCT02043392
Accepting New Patients
Intestinal Anastomosis Complication
Magnamosis
Study ID: NCT02431507
Accepting New Patients
Sleep Apnea, Sleep Disorders
Magnap
Study ID: NCT04291651
Accepting New Patients
Pancreatic Cyst, Pancreatic Cancer, Pancreatic Diseases, Pancreatic IPMN, IPMN, Pancreatic Ductal Adenocarcinoma, Mucinous Cyst
Survey
Study ID: NCT03682757
Accepting New Patients
Wound and Injuries, Blood Platelets, Endothelium
Study ID: NCT03508830
Accepting New Patients
Thoracic Diseases, Postoperative Pain, Opioid Use
Liposomal Bupivacaine, Standard Bupivacaine
Study ID: NCT03639025
Accepting New Patients
Lung Transplant
Study ID: NCT02986698
Accepting New Patients
Alpha Thalassemia, Alpha Thalassemia Major, Hemoglobinopathy, Anemia, Hydrops Fetalis, Hematopoietic Cell Transplantation
in utero hematopoietic stem cell transplantation
Study ID: NCT04532047
Not Yet Accepting Patients
Mucopolysaccharidosis, Mucopolysaccharidosis Type I, Hunter Syndrome, Mucopolysaccharidosis Type IVA, Mps VII, Gaucher Disease, Pompe Disease, Wolman Disease
Study ID: NCT02206984
Accepting New Patients
Breast Cancer
Tamoxifen, Anastrozole, Fulvestrant
Study ID: NCT02661386
Accepting New Patients
Motility Function, Anesthesia
Motility Procedure
Study ID: NCT02476474
Not Yet Accepting Patients
Obesity
3 cm start of resection, 6 cm start of resection
Study ID: NCT04186221
Accepting New Patients
Liver Transplant
OCS Liver System
Study ID: NCT03977662
Accepting New Patients
Diabetes, Diabetes Type 1
Co-transplantation of PTG with pancreatic islets
Study ID: NCT02741323
Accepting New Patients
HIV/AIDS, Kidney Disease, Kidney Transplant
Maraviroc, Placebo
Study ID: NCT03500315
Accepting New Patients
HIV/AIDS, Kidney Transplant
HIV D+/R+
Study ID: NCT03443869
Accepting New Patients
Cytomegalovirus, Human Cytomegalovirus, Kidney Transplant
Letermovir, Valganciclovir, Acyclovir (ACV), Placebo to ACV, Placebo to LET, Placebo to VGCV
Study ID: NCT03629080
Accepting New Patients
Cytomegalovirus, Kidney Transplant
HB-101 vaccine, placebo
Study ID: NCT02474667
Accepting New Patients
Delayed Graft Function
ANG-3777, Placebo
Study ID: NCT04066114
Accepting New Patients
Kidney Transplant
lulizumab pegol, antithymocyte globulin (rabbit), methylprednisolone, tocilizumab, Prednisone, everolimus, belatacept, mycophenolate mofetil, mycophenolic acid
Study ID: NCT03663335
Accepting New Patients
Kidney Transplant
CFZ533, Tacrolimus - MMF - +/- corticosteroids
Study ID: NCT03363945
Accepting New Patients
Kidney Transplant, Immunotherapy
MDR-101
Study ID: NCT02711826
Accepting New Patients
Kidney Transplant, Living Kidney Donor
Polyclonal Regulatory T Cells, Everolimus, Tacrolimus, Mycophenolate mofetil, Mycophenolic acid, Acetaminophen, Diphenhydramine, Biopsy, Kidney, Blood Draw, Leukapheresis, IS regimen conversion